Rib-X Pharmaceuticals, Inc.' RX-04 Program Will be Featured at Windhover Information Inc.'s Therapeutic Area Partnerships Meeting as a "Top 10 Infectious Diseases Project to Watch"
11/29/2012 9:51:54 AM
More...
|
Addex Therapeutics (ADXN.SW)' Dipraglurant Named as one of the "Top 10 Neuroscience Projects to Watch" by Windhover Information Inc. and Virginia Herndon
11/27/2012 9:56:51 AM
More...
|
Neogenix Oncology, Inc.'s Novel Antibody NEO-101 Named One of Windhover Information Inc.'s Top 10 Projects to Watch
11/30/2011 8:55:38 AM
More...
|
Alvine Pharmaceuticals, Inc.'s ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover Information Inc. for a Rare Second Year
11/29/2011 10:07:27 AM
More...
|
Naurex Inc.'s Novel Antidepressant GLYX-13 Recognized as One of Windhover Information Inc.'s 2011 Top 10 Neuroscience Projects to Watch
11/7/2011 12:29:19 PM
More...
|
Tivorsan Pharmaceuticals, Inc.' Biglycan for Duchenne Muscular Dystrophy Named One of Windhover Information Inc.'s Top 10 “Hot Space” Projects to Watch
10/19/2011 10:34:38 AM
More...
|
ImmunoCellular Therapeutics, Ltd' ICT-107 Recognized As One of Windhover’s Top 10 Most Licensable Oncology Products
9/28/2011 9:58:37 AM
More...
|
Local Medical-Devices Firms Face Tougher Times, Says Director of Windhover Information Inc.
1/3/2011 8:05:42 AM
More...
|
Stealth Peptides Inc.' Bendavia(TM) Recognized as One of Stealth Peptides Inc.'s Top 10 Cardiovascular and Metabolic Development Programs to Watch
11/8/2010 9:53:39 AM
More...
|
NormOxys, Inc.' Novel Oxygen-Enhancing Drug Candidate, OXY111A, Recognized as One of Windhover Information Inc.'s Top 10 Cardiovascular/Metabolic Projects to Watch
11/3/2010 11:41:14 AM
More...
|
|